Eli Lilly
-
{
- All
- News
- Videos
-
Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
- Saturday October 3, 2026
- Science | Edited by Nikhil Pandey
An experimental weekly weight-loss injection called retatrutide helped people with obesity lose an average of up to 25 per cent of their body weight after 80 weeks in a Phase 3 trial.
-
www.ndtv.com
-
Eli Lilly Gets US FDA Nod For Once-Weekly Onswik Insulin For Type 2 Diabetes
- Thursday September 24, 2026
- Author: NDTV Profit News
Lilly’s FDA approval is based on the QWINT Phase 3 programme, which evaluated Onswik in more than 3,400 adults with type 2 diabetes across four clinical trials.
-
www.ndtvprofit.com
-
Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial
- Monday September 21, 2026
- Author: NDTV Profit News
CagriSema is a weekly injection that blends cagrilintide, a compound that mimics the pancreatic hormone amylin, with semaglutide, the active component in Wegovy.
-
www.ndtvprofit.com
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
- Wednesday May 13, 2026
- Health | Written by Shreya Goswami
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
www.ndtv.com/health
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
- Wednesday May 13, 2026
- Health | Written by Shreya Goswami
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
www.ndtv.com/health
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Cipla To Sell Eli Lilly's Weight-Loss Drug As Yurpeak In India
- Thursday October 23, 2025
- Author: NDTV Profit Desk
The injector pen will be available in the following six doses — 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg and will be sold at the same price as the Mounjaro Kwikpen.
-
www.ndtvprofit.com
-
Eli Lilly's Mounjaro Becomes India's Second-Highest Selling Drug In September
- Tuesday October 7, 2025
- Author: NDTV Profit Desk
The top-selling drug for the month was GlaxoSmithKline's Augmentin, an antibiotic, which brought in Rs 85 crore in revenue.
-
www.ndtvprofit.com
-
Eli Lilly Shares Plunge 14% As Weight-Loss Pill Data Disappoints
- Thursday August 7, 2025
- Author: NDTV Profit Desk
Investors had expected Lilly’s pill 'orforglipron' to be as effective as Wegovy, a weight-loss injectable manufactured by Novo Nordisk.
-
www.ndtvprofit.com
-
Eli Lilly's Weight-Loss Drug Mounjaro Gets Thumbs Up From JM Financial — Here's Why
- Wednesday March 26, 2025
- Author: Ann Jacob
JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large addressable market.
-
www.ndtvprofit.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
- Saturday October 3, 2026
- Science | Edited by Nikhil Pandey
An experimental weekly weight-loss injection called retatrutide helped people with obesity lose an average of up to 25 per cent of their body weight after 80 weeks in a Phase 3 trial.
-
www.ndtv.com
-
Eli Lilly Gets US FDA Nod For Once-Weekly Onswik Insulin For Type 2 Diabetes
- Thursday September 24, 2026
- Author: NDTV Profit News
Lilly’s FDA approval is based on the QWINT Phase 3 programme, which evaluated Onswik in more than 3,400 adults with type 2 diabetes across four clinical trials.
-
www.ndtvprofit.com
-
Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial
- Monday September 21, 2026
- Author: NDTV Profit News
CagriSema is a weekly injection that blends cagrilintide, a compound that mimics the pancreatic hormone amylin, with semaglutide, the active component in Wegovy.
-
www.ndtvprofit.com
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
- Wednesday May 13, 2026
- Health | Written by Shreya Goswami
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
www.ndtv.com/health
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
- Wednesday May 13, 2026
- Health | Written by Shreya Goswami
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
www.ndtv.com/health
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
Cipla To Sell Eli Lilly's Weight-Loss Drug As Yurpeak In India
- Thursday October 23, 2025
- Author: NDTV Profit Desk
The injector pen will be available in the following six doses — 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg and will be sold at the same price as the Mounjaro Kwikpen.
-
www.ndtvprofit.com
-
Eli Lilly's Mounjaro Becomes India's Second-Highest Selling Drug In September
- Tuesday October 7, 2025
- Author: NDTV Profit Desk
The top-selling drug for the month was GlaxoSmithKline's Augmentin, an antibiotic, which brought in Rs 85 crore in revenue.
-
www.ndtvprofit.com
-
Eli Lilly Shares Plunge 14% As Weight-Loss Pill Data Disappoints
- Thursday August 7, 2025
- Author: NDTV Profit Desk
Investors had expected Lilly’s pill 'orforglipron' to be as effective as Wegovy, a weight-loss injectable manufactured by Novo Nordisk.
-
www.ndtvprofit.com
-
Eli Lilly's Weight-Loss Drug Mounjaro Gets Thumbs Up From JM Financial — Here's Why
- Wednesday March 26, 2025
- Author: Ann Jacob
JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large addressable market.
-
www.ndtvprofit.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com